Bumper Offer - Urjas oil Just @ Rs. 1
Escigress 5 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Depression. Other than this, Escigress 5 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Escigress 5 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Escigress 5 Tablet can also lead to other problems, which have been listed below. Such side effects of Escigress 5 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Escigress 5 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. Further, the section on Escigress 5 Tablet related warnings talks about Escigress 5 Tablet's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Escigress 5 Tablet contraindications section.
Drug interactions for Escigress 5 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Escigress 5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Escigress 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Escigress 5 Tablet is used -
Moderate
Mild
Is the use of Escigress 5 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Escigress. It is best to stop taking Escigress immediately and inform your doctor if you notice any discomfort.
Is the use of Escigress 5 Tablet safe during breastfeeding?
Taking Escigress may lead to serious side effects if you are breastfeeding. Escigress should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Escigress 5 Tablet on the Kidneys?
Escigress rarely harms the kidneys.
What is the effect of Escigress 5 Tablet on the Liver?
Side effects of Escigress rarely affect the liver.
What is the effect of Escigress 5 Tablet on the Heart?
Escigress has very mild side effects on the heart.
Escigress 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Escigress 5 Tablet unless your doctor advises you to do so -
Is this Escigress 5 Tablet habit forming or addictive?
Escigress 5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Escigress 5 Tablet, you should not drive or work on any heavy machine, as Escigress 5 Tablet can make you drowsy.
Is it safe?
Yes, but consume Escigress 5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, this Escigress 5 Tablet works for mental disorders.
Interaction between Food and Escigress 5 Tablet
Taking Escigress 5 Tablet with food does not harm your health.
Interaction between Alcohol and Escigress 5 Tablet
Consult your doctor before consuming alcohol while taking Escigress 5 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
